HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech PharmTech 100

Insilico Medicine

1
Articles
Primary Subject
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
2.15
Relevance Score
PharmTech 100 Profile
Category
ai-discovery
Founded
2014
Headquarters
New York, NY
Funding
Series D
Website
www.insilico.com
About
End-to-end AI drug discovery platform using generative AI for target identification, molecule design, and clinical trial prediction.

Coverage Timeline

April 2026
AI-Discovered Antibiotics Hit the Clinic: Hype, Resistance, and the Harsh Economics Pipeline Primary Subject
Apr 11, 2026
Insilico’s ISM-001, discovered with generative adversarial networks and multi-objective optimization, stands as evidence of what’s possible.
Related Companies
Paratek Pharmaceuticals, Inc.
1 shared
Spero Therapeutics, Inc.
1 shared
Iktos
1 shared
Merck & Co., Inc.
1 shared
Pfizer Inc.
1 shared